E-LIB Suche - Ergebnisse für: Ballard, Peter

1

A unique soft tissue injury with devastating delayed conseq..:

Tipton, Kay Nicole ; Lakey, Jody ; Ballard, Peter.
Journal of the American College of Emergency Physicians Open. 4 (2023) 2 - p. , 2023

Link: https://doi.org/10.1002/..

2

Metabolism of (R)‐Praziquantel versus the Activation of a P..:

Friedrich, Lukas ; Park, Sang‐Kyu ; Ballard, Peter...
ChemMedChem. 18 (2023) 18 - p. , 2023

Link: https://doi.org/10.1002/..

3

Development, Verification, and Prediction of Osimertinib Dr..:

Pilla Reddy, Venkatesh ; Walker, Michael ; Sharma, Pradeep..
CPT: Pharmacometrics & Systems Pharmacology. 7 (2018) 5 - p. 321-330 , 2018

Link: https://doi.org/10.1002/..

4

Discovery and Optimization of a Novel Series of Dyrk1B Kina..:

Kettle, Jason G. ; Ballard, Peter ; Bardelle, Catherine...
Journal of Medicinal Chemistry. 58 (2015) 6 - p. 2834-2844 , 2015

Link: https://doi.org/10.1021/..

5

Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluor..:

De Savi, Chris ; Bradbury, Robert H. ; Rabow, Alfred A....
Journal of Medicinal Chemistry. 58 (2015) 20 - p. 8128-8140 , 2015

Link: https://doi.org/10.1021/..

6

Discovery of a Potent and Selective EGFR Inhibitor (AZD9291..:

Finlay, M. Raymond V. ; Anderton, Mark ; Ashton, Susan...
Journal of Medicinal Chemistry. 57 (2014) 20 - p. 8249-8267 , 2014

Link: https://doi.org/10.1021/..

7

Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypr..:

Addie, Matt ; Ballard, Peter ; Buttar, David...
Journal of Medicinal Chemistry. 56 (2013) 5 - p. 2059-2073 , 2013

Link: https://doi.org/10.1021/..

8

Discovery of AZD8931, an Equipotent, Reversible Inhibitor o..:

Barlaam, Bernard ; Anderton, Judith ; Ballard, Peter...
ACS Medicinal Chemistry Letters. 4 (2013) 8 - p. 742-746 , 2013

Link: https://doi.org/10.1021/..

9

Small-molecule androgen receptor downregulators as an appro..:

Bradbury, Robert H. ; Hales, Neil J. ; Rabow, Alfred A....
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 18 - p. 5442-5445 , 2011

Link: https://doi.org/10.1016/..

10

Novel thienopyrimidine and thiazolopyrimidine kinase inhibi..:

Luke, Richard W.A. ; Ballard, Peter ; Buttar, David...
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 23 - p. 6670-6674 , 2009

Link: https://doi.org/10.1016/..

11

Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and er..:

Ducray, Richard ; Ballard, Peter ; Barlaam, Bernard C....
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 3 - p. 959-962 , 2008

Link: https://doi.org/10.1016/..

12

A new series of neutral 5-substituted 4-anilinoquinazolines..:

Barlaam, Bernard ; Ballard, Peter ; Bradbury, Robert H....
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 2 - p. 674-678 , 2008

Link: https://doi.org/10.1016/..

13

Neutral 5-substituted 4-indazolylaminoquinazolines as poten..:

Barlaam, Bernard ; Acton, David G. ; Ballard, Peter...
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 6 - p. 1799-1803 , 2008

Link: https://doi.org/10.1016/..

14

Neutral 5-substituted 4-anilinoquinazolines as potent, oral..:

Ballard, Peter ; Barlaam, Bernard C. ; Bradbury, Robert H....
Bioorganic & Medicinal Chemistry Letters. 17 (2007) 22 - p. 6326-6329 , 2007

Link: https://doi.org/10.1016/..

15

Inhibitors of epidermal growth factor receptor tyrosine kin..:

Ballard, Peter ; Bradbury, Robert H. ; Harris, Craig S....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 6 - p. 1633-1637 , 2006

Link: https://doi.org/10.1016/..